PF-670462 100 mg | 99.42%
TargetMol
PF-670462 is a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 additional kinases) inhibitor of CK1ε in isolated enzyme preparations.
More Information Supplier Page
PF-670462 is a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 additional kinases) inhibitor of CK1ε in isolated enzyme preparations.
More Information Supplier Page
5α-Cholestan-3β-ol (NSC 18188) is a cholesterol derivative found in human feces, gallstones, eggs, and other biological matter.
More Information Supplier Page
Troglitazone is a PPARγ agonist with anti-inflammatory and anti-tumor activity.
More Information Supplier Page
APD597 is a GPR119 agonist, used in the treatment of type 2 diabetes.
More Information Supplier Page
WDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM).
More Information Supplier Page
WDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM).
More Information Supplier Page
WDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM).
More Information Supplier Page
Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.
More Information Supplier Page
Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.
More Information Supplier Page
Sulfisomidin (Sulfaisodimidine) is a short-acting antibacterial agent.
More Information Supplier Page